Status:

RECRUITING

The Objective of This Study is to Evaluate the Perfomance of a Photorefraction Device for Screening Ametropia in Children. Eligible Participants Will Undergo Multiple Refractive Error Measurements, Visual Acuity and Strabismus Assessments During a Single Evaluation Visit.

Lead Sponsor:

Essilor International

Conditions:

Ametropia

Myopia; Refractive Error

Eligibility:

All Genders

3-8 years

Phase:

NA

Brief Summary

The goal of this clinical trial is to evaluate the performance of a photorefraction screener in terms of sensibility, sensitivity and accuracy on children aged 3 to 8 y.o. The main objectives of the s...

Detailed Description

Participants after verification of their eligibility and informed consent, participate to a single evaluation visit during which several objective refraction measurements are performed with the invest...

Eligibility Criteria

Inclusion

  • Aged between 3-8 years when included in the study
  • All skin phototypes (I to VI according to the Fitzpatrick classification)
  • Wearing glasses or not
  • Capacity to give valid consent
  • Capacity to follow the protocol to obtain reliable measure
  • Under French medical insurance

Exclusion

  • Under myopia control solution that may have an impact on refractive error (such as: atropine, orthokeratology,..)
  • Wearing contact lenses
  • Ocular or systemic pathology that may have an impact on vision or may interfere with the study measures (except strabismus)
  • Under medication that may have an impact on vision or may interfere with study measurements
  • Known contraindication to the active substance or to one of the excipients of eye drops (Mydriaticum 0.5%, Skiacol 0.5%)
  • Known risk of angle-closure glaucoma
  • Participation to another study that may have an impact on vision or may interfere with the study measures

Key Trial Info

Start Date :

April 1 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 1 2025

Estimated Enrollment :

315 Patients enrolled

Trial Details

Trial ID

NCT06882408

Start Date

April 1 2025

End Date

December 1 2025

Last Update

April 29 2025

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Dr Krafft private practice

Nancy, France, France, 54000

2

Hôpital civil de Strasbourg

Strasbourg, France, France, 67091

The Objective of This Study is to Evaluate the Perfomance of a Photorefraction Device for Screening Ametropia in Children. Eligible Participants Will Undergo Multiple Refractive Error Measurements, Visual Acuity and Strabismus Assessments During a Single Evaluation Visit. | DecenTrialz